Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$42.3M |
| 2 |
United Parcel Service
UPS
|
+$34.7M |
| 3 |
Lumen
LUMN
|
+$28.1M |
| 4 |
Invitation Homes
INVH
|
+$26.7M |
| 5 |
Progressive
PGR
|
+$25.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$90.4M |
| 2 |
Dell
DELL
|
+$67.6M |
| 3 |
LVLT
Level 3 Communications Inc
LVLT
|
+$64.9M |
| 4 |
AT&T
T
|
+$36.5M |
| 5 |
Automatic Data Processing
ADP
|
+$35.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.06% |
| 2 | Healthcare | 14.62% |
| 3 | Consumer Discretionary | 11.07% |
| 4 | Industrials | 10.59% |
| 5 | Communication Services | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Agios Pharmaceuticals
AGIO
$1.95B
| $4M | ﹤0.01% |
70,060
+1,600
| +2% | +$101K |
|
|
BWLD
1202
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $4M | ﹤0.01% |
25,600
| – | – |
|
|
ERF
1203
DELISTED
Enerplus Corporation
ERF
| $4M | ﹤0.01% |
408,155
| – | – |
|
1204
Itron
ITRI
$4.49B
| $4M | ﹤0.01% |
58,600
+1,200
| +2% | +$85.8K |
|
1205
B&G Foods
BGS
$276M
| $3.98M | ﹤0.01% |
113,300
+2,100
| +2% | +$71.9K |
|
|
QEP
1206
DELISTED
QEP RESOURCES, INC.
QEP
| $3.98M | ﹤0.01% |
415,742
+14,000
| +3% | +$127K |
|
|
MNDT
1207
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $3.96M | ﹤0.01% |
279,200
+13,000
| +5% | +$198K |
|
1208
Hope Bancorp
HOPE
$1.79B
| $3.95M | ﹤0.01% |
216,657
+4,800
| +2% | +$87.1K |
|
|
ARRY
1209
DELISTED
Array Biopharma Inc
ARRY
| $3.95M | ﹤0.01% |
308,700
+6,300
| +2% | +$71.7K |
|
|
FNSR
1210
DELISTED
Finisar Corp
FNSR
| $3.95M | ﹤0.01% |
194,000
+9,600
| +5% | +$200K |
|
|
XIFR
1211
XPLR Infrastructure LP
XIFR
$1.07B
| $3.94M | ﹤0.01% |
91,400
+2,000
| +2% | +$80.4K |
|
|
AXE
1212
DELISTED
Anixter International Inc
AXE
| $3.94M | ﹤0.01% |
51,800
+1,800
| +4% | +$132K |
|
|
GWB
1213
DELISTED
Great Western Bancorp, Inc.
GWB
| $3.93M | ﹤0.01% |
98,700
| – | – |
|
1214
Silgan Holdings
SLGN
$4.35B
| $3.93M | ﹤0.01% |
133,600
+4,500
| +3% | +$130K |
|
1215
Hudbay
HBM
$12.4B
| $3.93M | ﹤0.01% |
443,000
+8,900
| +2% | +$69.4K |
|
|
XHR
1216
Xenia Hotels & Resorts
XHR
$1.74B
| $3.92M | ﹤0.01% |
181,780
+4,900
| +3% | +$107K |
|
1217
Red Rock Resorts
RRR
$3.58B
| $3.92M | ﹤0.01% |
116,100
+2,800
| +2% | +$78.1K |
|
|
PRMW
1218
DELISTED
Primo Water Corporation
PRMW
| $3.92M | ﹤0.01% |
234,500
| – | – |
|
1219
Dr. Reddy's Laboratories
RDY
$10.1B
| $3.91M | ﹤0.01% |
520,810
| – | – |
|
1220
GATX Corp
GATX
$6.23B
| $3.91M | ﹤0.01% |
62,900
| – | – |
|
1221
Semtech
SMTC
$12.2B
| $3.91M | ﹤0.01% |
114,200
+5,700
| +5% | +$213K |
|
|
MGLN
1222
DELISTED
Magellan Health Services, Inc.
MGLN
| $3.89M | ﹤0.01% |
40,300
+1,000
| +3% | +$88.5K |
|
|
GCP
1223
DELISTED
GCP Applied Technologies Inc.
GCP
| $3.89M | ﹤0.01% |
121,900
+2,600
| +2% | +$79.9K |
|
1224
Simpson Manufacturing
SSD
$8.03B
| $3.88M | ﹤0.01% |
67,600
| – | – |
|
1225
UFP Industries
UFPI
$5.01B
| $3.88M | ﹤0.01% |
103,050
| – | – |
|
Similar funds
Swiss National Bank's Q4 2017 Portfolio in Review
As of Q4 2017, Swiss National Bank held 2,605 positions worth $92.6B, up 5.4% from $87.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Swiss National Bank's Q4 2017 filing shows 77 new, 1,182 increased, 249 reduced and 91 closed positions. Its largest new stake was Invitation Homes: 1,152,016 shares worth $27.2M. The largest sale was CR Bard Inc., an estimated $90.4M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q4 2017 buy was Invitation Homes: 1,152,016 shares worth $27.2M.
- Swiss National Bank added most to Amphenol in Q4 2017, an estimated $42.3M increase.
- Swiss National Bank's biggest Q4 2017 reduction was Dell, cutting an estimated $67.6M.
- Swiss National Bank fully exited CR Bard Inc. in Q4 2017, selling an estimated $90.4M.
- Swiss National Bank's ten largest holdings make up 17% of its $92.6B portfolio in Q4 2017.
- Swiss National Bank opened 77 new positions and closed 91 in Q4 2017.
- Swiss National Bank's portfolio value rose 5.4% quarter-over-quarter to $92.6B.
Based on Swiss National Bank's 13F filing for Q4 2017, filed 7 Feb 2018.